LONG COVID-19

This study tested the antiviral drug Paxlovid in 964 adults with Long COVID to see if it could improve symptoms like brain fog, dizziness, and fatigue. Participants received either a short or longer course of Paxlovid or a placebo. The goal was to find out if clearing leftover vi…

This study tested different methods to help people with Long COVID who have trouble exercising or feel very tired after activity. About 300 adults who developed these symptoms after a COVID-19 infection took part. Researchers measured changes in symptoms like post-exertional mala…

This study tested different treatments to help people with Long COVID who have trouble sleeping. It included 830 adults and looked at two main sleep problems: feeling very sleepy during the day and having trouble falling or staying asleep. The goal was to find which treatments wo…

This study tested whether ivabradine, a heart medication, can reduce symptoms like dizziness and rapid heart rate in people with long COVID. 181 participants received either ivabradine or a placebo. The goal was to see if the drug improves daily activities and symptom severity.

This study tested different treatments to help people with Long COVID who struggle with exercise and feel very tired after activity. Researchers enrolled 660 adults across multiple medical centers. The goal was to find ways to improve daily activity and quality of life.

This study tested different treatments for autonomic dysfunction—problems with heart rate, blood pressure, and digestion—in people with Long COVID. 381 adults with suspected or confirmed prior COVID-19 infection participated. The goal was to find which therapies, including medica…

This study tested a 9-week program combining group education and physical rehabilitation for people with Long COVID. 74 adults participated to see if the program could improve quality of life, mental well-being, and physical condition while reducing anxiety, depression, and fatig…